Speaker(s): 

E. Kelly Hester, PharmD, FCCP, BCPS, AAHIVP, Staff Member, Auburn University Harrison College of Pharmacy - has disclosed receiving honoraria from ViiV [Consultant Advisor].

Moderator(s): 

Daniel Longyhore, PharmD, Ed.D., BCACP, Staff Member, Geisinger - has nothing to disclose.   

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• recommend patients who should be screened for HIV infection. 
• discuss outcomes of early initiation of antiretroviral therapy. 
• recommend appropriate pharmacotherapy for primary cardiovascular risk reduction.
• identify and manage antiretroviral drug-drug interactions.
• recognize drug-related problems with contemporary antiretroviral therapy.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Daniel Longyhore, PharmD, Ed.D., BCACP; Eric Wright, PharmD, MPH; Melissa Kern, MPH; Lisabeth Karetsky, CPhT and Nichole Varela Gonzalez have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose.

Dan Dometita, DO and Andrea Dimattia, EdD; have nothing to disclosure.

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.